CoChat

Basal Insulin Analogs versus Neutral Protamine Hagedorn for Type 2 Diabetics

Fishel Bartal, Michal, Ward, Clara, Refuerzo, Jerrie S., Ashimi, Sunbola S., Joycelyn, Cornthwaite A., Chen, Han-Yang, Chauhan, Suneet P., Sibai, Baha M. · 2020 · American Journal of Perinatology

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Objective To determine whether basal insulin analogs reduce the rate of composite neonatal morbidity compared with neutral protamine Hagedorn (NPH) in women with type 2 diabetes mellitus (T2DM). Study Design This was a retrospective cohort study of women with T2DM and singleton pregnancy at a single tertiary center. Primary outcome was a composite neonatal morbidity of any of the following: shoulder dystocia, large for gestational age, neonatal intensive care unit admission, neonatal hypoglycemia, or respiratory distress syndrome. Secondary outcomes were rates of maternal hypoglycemic events, hypertensive disorders, preterm birth, and primary cesarean delivery. Adjusted relative risk (aRR) and 95% confidence intervals (CI) were calculated. Results Of 233 women with T2DM that met the inclusion criteria, 114 (49%) were treated with basal insulin analogs and 119 (51%) with NPH. The rate of composite neonatal morbidity was similar between groups (73 vs. 60%; aRR: 1.18; 95% CI: 0.92–1.51). There were no differences in the rates of maternal adverse outcomes between the groups. Basal insulin analog was associated with a lower rate of primary cesarean delivery as compared with NPH (21 vs. 36%; aRR: 0.44; 95% CI: 0.25–0.78). Conclusion Among pregnant women with T2DM managed with either basal or NPH insulin regimen, the rates of composite neonatal morbidity and maternal complications were similar.

Overview

Integrity signals

Registry

Crossref · 10.1055/s-0039-1694733

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 25 references

Cited by

See all 8

Metadata

Authors
Fishel Bartal, M., Ward, C., Refuerzo, J. S., Ashimi, S. S., Joycelyn, C. A., Chen, H.-Y., Chauhan, S. P., & Sibai, B. M.
Affiliations
  • Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas
  • The University of Texas Health Science Center at Houston (US)
Venue
American Journal of Perinatology
Published
2019-08-20
Volume
37
Issue
01
Pages
030-036
ISSN
  • 0735-1631 (ISSN-L)
  • 1098-8785
OpenAlex
W2969573621
Cited by
8
References
25
Citations by year
2025: 1 · 2024: 1 · 2023: 1 · 2022: 4 · 2021: 1
FWCI
1.36
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Perinatology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
basal insulin analogues, type 2 diabetes, pregnancy, neonatal morbidity, shoulder dystocia, large for gestational age, neonatal intensive care admission, neonatal hypoglycemia, respiratory distress syndrome, maternal hypoglycemia, hypertensive disorders, preterm birth, cesarean section
MeSH terms
Insulin Glargine, Insulin Detemir, Adult, Diabetes Mellitus, Type 2, Female, Humans, Hypoglycemia, Hypoglycemic Agents, Infant, Newborn, Infant, Newborn, Diseases, Insulin, Isophane, Pregnancy, Pregnancy in Diabetics, Pregnancy Outcome, Retrospective Studies, Logistic Models, Premature Birth, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Basal Insulin Analogs versus Neutral Protamine Hagedorn for Type 2 Diabetics. https://app.cochat.ai/papers/10.1055/s-0039-1694733
The paper
Fishel Bartal, M., Ward, C., Refuerzo, J. S., Ashimi, S. S., Joycelyn, C. A., Chen, H.-Y., Chauhan, S. P., & Sibai, B. M. (2020). Basal Insulin Analogs versus Neutral Protamine Hagedorn for Type 2 Diabetics. American Journal of Perinatology. https://doi.org/10.1055/s-0039-1694733

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.